رجوع
مُدرج أيضًا باسم
OLYMY
OTC
نطاق اليوم
KWD 8.55
KWD 8.55
نطاق 52 أسبوعًا
KWD 8.00
KWD 14.00
حجم التداول
15
متوسط 50 يوم / 200 يوم
KWD 10.83
/
KWD 12.07
الإغلاق السابق
KWD 8.61
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.2 |
| P/B | 0.0 | 3.0 |
| ROE % | 15.6 | 3.6 |
| Net Margin % | 11.8 | 3.8 |
| Rev Growth 5Y % | 8.1 | 9.9 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 126.93
KWD 124.00 – KWD 131.20
|
1.16T | 1 |
| FY2029 |
KWD 119.14
KWD 116.39 – KWD 123.15
|
1.12T | 1 |
| FY2028 |
KWD 108.13
KWD 105.63 – KWD 111.77
|
1.09T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | KWD 23.08 | KWD 0.08 | -99.6% |
| 2025-05-13 | KWD 0.16 | KWD 0.25 | +60.7% |
| 2025-02-12 | KWD 0.22 | KWD 0.15 | -31.1% |
| 2024-11-08 | KWD 0.22 | KWD 0.20 | -8.8% |
| 2024-08-07 | KWD 0.09 | KWD 0.08 | -13.9% |
| 2024-05-10 | KWD 0.11 | KWD 0.04 | -60.8% |
| 2024-02-14 | KWD 0.16 | KWD 0.11 | -30.2% |
| 2023-09-30 | KWD 0.17 | -KWD 0.13 | -177.3% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.18%
Growth (3Y)
5.13%
Growth (5Y)
7.53%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Jun 01, 2026 | KWD 0.19 | 2.21% |
| Mar 31, 2025 | Jun 05, 2025 | KWD 0.13 | 0.96% |
| Mar 28, 2024 | Jun 05, 2024 | KWD 0.12 | 0.82% |
| Mar 30, 2023 | Jun 06, 2023 | KWD 0.12 | 0.70% |
| Mar 30, 2022 | Jun 03, 2022 | KWD 0.11 | 0.60% |
| Mar 30, 2021 | Jun 03, 2021 | KWD 0.11 | 0.49% |
| May 28, 2020 | Jul 31, 2020 | KWD 0.09 | 0.67% |
| Mar 27, 2019 | Jun 26, 2019 | KWD 0.27 | 0.62% |
| Mar 28, 2018 | Jun 27, 2018 | KWD 0.26 | 2.73% |
| Mar 29, 2017 | Jun 29, 2017 | KWD 0.25 | 0.72% |
| Mar 29, 2016 | Jun 29, 2016 | KWD 0.15 | 1.54% |
| Mar 27, 2015 | Jun 29, 2015 | KWD 0.08 | 0.22% |
| Mar 29, 2011 | Jun 30, 2011 | KWD 0.18 | 1.33% |
| Sep 28, 2010 | Dec 03, 2010 | KWD 0.18 | 1.39% |
| Mar 29, 2010 | Jun 30, 2010 | KWD 0.16 | 1.06% |
| Sep 25, 2009 | Dec 04, 2009 | KWD 0.17 | 0.63% |
| Sep 25, 2008 | Dec 05, 2008 | KWD 0.19 | 1.47% |
| Mar 26, 2008 | Jun 30, 2008 | KWD 0.20 | 1.42% |
| Sep 25, 2007 | Dec 07, 2007 | KWD 0.17 | 1.37% |
| Mar 27, 2007 | Jun 29, 2007 | KWD 0.20 | 0.88% |
النقاط الرئيسية
Revenue grew 8.09% annually over 5 years — modest growth
Earnings declined -51.41% over the past year
ROE of 15.62% — decent returns on equity
Debt/Equity of 0.30 — conservative balance sheet
Generating 125.25B in free cash flow
P/E of 0.08 — trading at a low valuation
النمو
Revenue Growth (5Y)
8.09%
Revenue (1Y)6.53%
Earnings (1Y)-51.41%
FCF Growth (3Y)112.01%
الجودة
Return on Equity
15.62%
ROIC12.42%
Net Margin11.82%
Op. Margin16.29%
الأمان
Debt / Equity
0.30
Current Ratio1.60
Interest Coverage23.75
التقييم
P/E Ratio
0.08
Forward P/E0.16
P/B Ratio0.01
EV/EBITDA-0.09
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.53% | Revenue Growth (3Y) | 6.34% |
| Earnings Growth (1Y) | -51.41% | Earnings Growth (3Y) | -9.35% |
| Revenue Growth (5Y) | 8.09% | Earnings Growth (5Y) | 73.80% |
| Profitability | |||
| Revenue (TTM) | 997.33B | Net Income (TTM) | 117.86B |
| ROE | 15.62% | ROA | 8.23% |
| Gross Margin | 68.55% | Operating Margin | 16.29% |
| Net Margin | 11.82% | Free Cash Flow (TTM) | 125.25B |
| ROIC | 12.42% | FCF Growth (3Y) | 112.01% |
| Safety | |||
| Debt / Equity | 0.30 | Current Ratio | 1.60 |
| Interest Coverage | 23.75 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.18% |
| Dividend Growth (3Y) | 5.13% | Dividend Growth (5Y) | 7.53% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.08 | Forward P/E | 0.16 |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | 0.05 | Forward PEG | N/A |
| EV/EBITDA | -0.09 | Fwd EV/EBITDA | -0.06 |
| Forward P/S | 0.01 | Fwd Earnings Yield | 625.00% |
| FCF Yield | 1330.49% | ||
| Market Cap | 9.41B | Enterprise Value | -14.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 997.33B | 936.21B | 881.92B | 868.87B | 730.54B |
| Net Income | 117.86B | 242.57B | 143.43B | 115.74B | 12.92B |
| EPS (Diluted) | 102.80 | 21.88 | 108.65 | 90.17 | 51.00 |
| Gross Profit | 683.70B | 625.12B | 562.70B | 475.99B | 427.99B |
| Operating Income | 162.46B | 151.89B | 186.61B | 166.30B | 102.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.43T | 1.53T | 1.51T | 1.36T | 1.18T |
| Total Liabilities | 681.09B | 777.03B | 865.32B | 844.60B | 785.55B |
| Shareholders' Equity | 751.73B | 757.19B | 640.09B | 510.17B | 394.33B |
| Total Debt | 229.10B | 299.62B | 340.06B | 386.13B | 355.26B |
| Cash & Equivalents | 252.53B | 340.93B | 164.55B | 294.58B | 173.28B |
| Current Assets | 679.44B | 800.34B | 726.36B | 694.61B | 580.07B |
| Current Liabilities | 425.36B | 431.70B | 461.89B | 376.25B | 328.39B |
درجات الاستراتيجيات
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
خرج
Contrarian Investing (David Dreman)
Mar 26, 2026
خرج
Defensive Investing (Benjamin Graham)
Mar 26, 2026
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026
دخل
Balanced Risk
Mar 24, 2026